Min.Order / FOB Price:Get Latest Price
10 Metric Ton |
Negotiable |
GW501516 MK2866 SARMS
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 | A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW501516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
SR9011 | 1379686-30-2 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 |
366508-78-3 431579-34-9 |
a SARM and myostatin inhibitor in one |
CAS NO:148553-50-8
CAS NO:82640-04-8
CAS NO:96829-58-2
CAS NO:53-43-0
CAS NO:846-48-0
CAS NO:106505-90-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View